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PROGRAM
BRIEF

PROVIDERS’ ATTITUDES AND PRACTICES REGARDING
EMERGENCY CONTRACEPTION IN INDIA: KEY FINDINGS

FEBRUARY 2012

By M.E. Khan, Isha Bhatnagar, Deepthi S. Varma, and Anvita Dixit

BACKGROUND
The emergency contraceptive pill (ECP) is an
effective postcoital contraceptive method,
providing women with the opportunity to avoid
unwanted pregnancy after sex in which a
contraceptive either was not used or failed. In
India, where unintended pregnancy rates are high,
ECP was included in the National Family Planning
Program in 2002 and made an over-the-counter
(OTC) drug in 2005. Since ECP has been made
available OTC, concerns have been raised that the
easy availability and lack of knowledge regarding
correct use of ECP—even among providers—may
lead to its misuse, its repeat use within the same
menstrual cycle, replacement of precoital family
planning methods, and an increase in promiscuity.
Although no serious harmful effects have been
associated with repeat use of ECP, the method
should not be used repeatedly because it is less
reliable than other modern methods of birth
spacing.
OBJECTIVE
The present study explores providers’ knowledge
of how ECP works and its safety and
effectiveness, their perceptions of the frequency
of repeat use, their provision of ECP, and their
attitudes toward women who seek it.

METHODOLOGY
A quantitative survey of 315 providers—199
pharmacists, 83 OB/GYN doctors, 33
paramedics—was conducted in four cities of Uttar
Pradesh (Agra, Aligarh, Kanpur, and Lucknow) and
in Delhi. The sampling frame for Uttar Pradesh was
drawn from a list of doctors and pharmacies
provided by the Urban Health Initiative. The
sampling frame for Delhi was limited to
pharmacies and was created by dividing the city
into four sections and randomly sampling
pharmacies from each section. (A qualitative study
of 19 key opinion leaders was also conducted, and
those findings are presented elsewhere.)
FINDINGS
Most of the doctors (96 percent) knew the
mechanism by which ECP prevents pregnancy.
In contrast, 40 percent of paramedics and 61
percent of pharmacists lacked such knowledge.
Eighty-six percent of providers believed that
ECP is safe, and 82 percent thought it was very
effective in preventing pregnancy.
Forty-three percent of doctors, 24 percent of
paramedics, and only 11 percent of
pharmacists had ever received training in ECP.

Very few (13 percent) had received literature on ECP,
provided mainly by pharmaceutical firms.
Ninety percent of doctors, 72 percent of paramedics,
and 55 percent of pharmacists knew that ECP cannot
induce abortion.
Many doctors and paramedics mistakenly believed
that ECP cannot be used by women with heart
problems or who are breastfeeding.
Doctors expressed greater reservations than did
other providers about ECP use, distribution as an OTC
drug, and provision by paramedics.
Male providers were more than three times as likely
as female providers (OR=3.5, p<0.01) to support
availability of ECP as an OTC drug.
Logistic regression analysis showed that providers
who are male, young (aged 15–35 years), and trained
were two times as likely to support ECP provision,
compared with their female, older (35+), and
untrained counterparts, respectively.
The majority of providers (72 percent of pharmacists,
57 percent doctors) believed that many women are
using ECP repeatedly, but not necessarily in the same
cycle.

TABLE 1 Percentage of providers expressing various
attitudes toward ECP (N=315)
Attitude

Doctors
(n = 83)

Paramedics
(n = 33)

Pharmacists
(n = 199)

Disapproved of OTC
availability of ECP

67

61

34

Believed ECP use
among unmarried girls
is appropriate

29

33

49

Favored minimum-age
restriction for ECP use

84

94

74

Believed ECP use will
promote promiscuity

45

59

46

Believed people may
use ECP as regular
contraceptive

39

30

31

Approved provision of
ECP as prophylactic

48

58

58

POLICY IMPLICATIONS
Many of the findings of this study are encouraging.
Most providers believed that ECP is an effective and
safe method to prevent pregnancy and that it cannot
induce abortion, and half supported the OTC
provision of ECP. Although most providers (88–92
percent) viewed married women as the most
appropriate users of ECP, 42 percent approved its
use among unmarried girls. Nevertheless, the study
revealed many biases and gaps in knowledge. The
majority of doctors oppose OTC availability of ECP
and its provision by those lacking medical training.
Few providers reported receiving any orientation or
literature regarding ECP. The study also found that in
urban areas, particularly large cities like Delhi, ECP
use is common, and that many users are young and
unmarried. Repeated use of ECP is confirmed by
pharmacists who have returning customers. These
findings suggest that the following steps should be
taken:
1. An educational campaign is needed to overcome
the negative attitudes toward ECP among doctors
and other stakeholders.
2. Advertisements for condoms and the pill should
mention ECP as a backup method.
3. Companies that advertise their ECP brand on TV
and in newspapers should state clearly that ECP is
not intended for use as a primary contraceptive
method. Similarly, ECP packaging should state
that it is only for emergency use.
4. Medical representatives, wholesalers, and
pharmacists’ associations should educate
pharmacists about the correct use of ECP and,
when possible, provide a brochure explaining how
ECP works and its correct use.
5. A formative study should be undertaken to assess
the feasibility of using pharmacies—the main
direct supply point for ECP—as a source of
information for ECP users.
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